EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections

Richard I Horowitz, John Fallon, Phyllis R Freeman iD

Microorganisms · 12.09.2023 · 11 (9) · 2301

DOI: 10.3390/microorganisms11092301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 12.09.2023. Verfasst von Richard I Horowitz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lyme and Tick-Borne Diseases Working Group, New York State Department of Health, Albany, NY 12224, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 342 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MSIDS Research Foundation (MRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Twenty-five patients with relapsing and remitting Borreliosis, Babesiosis, and bartonellosis despite extended anti-infective therapy were prescribed double-dose dapsone combination therapy (DDDCT), followed by one or several courses of High Dose Dapsone Combination Therapy (HDDCT). A retrospective chart review of these 25 patients undergoing DDDCT therapy and HDDCT demonstrated that 100% improved their tick-borne symptoms, and patients completing 6–7 day pulses of HDDCT had superior levels of improvement versus 4-day pulses if Bartonella was present. At the completion of treatment, 7/23 (30.5%) who completed 8 weeks of DDDCT followed by a 5–7 day pulse of HDDCT remained in remission for 3–9 months, and 3/23 patients (13%) who recently finished treatment were 1 ½ months in full remission. In conclusion, DDDCT followed by 6–7 day pulses of HDDCT could represent a novel, effective anti-infective strategy in chronic Lyme disease/Post Treatment Lyme Disease Syndrome (PTLDS) and associated co-infections, including Bartonella, especially in individuals who have failed standard antibiotic protocols.

Schlagwörter

Stichwörter der Autor:innen

Lyme diseasebabesiosisbartonellosisdapsone combination therapy (DDSCT)double-dose dapsone combination therapy (DDDCT)florescent in situ hybridization (FISH)high-dose dapsone combination therapy (HDDCT)persistent infectionpost-treatment Lyme disease syndrome (PTLDS)

Autor:innen und Institutionen

  • Lyme and Tick-Borne Diseases Working Group, New York State Department of Health, Albany, NY 12224, USA.
  • Hudson Valley Healing Arts Center, Hyde Park, NY 12538, USA.

ORCID-Profile: Phyllis R Freeman

Förderung

  • MSIDS Research Foundation (MRF)

Zitieren

APA

Horowitz, R. I., Fallon, J., & Freeman, P. R. (2023). Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections. Microorganisms, 11(9), 2301. https://doi.org/10.3390/microorganisms11092301

Vancouver

Horowitz RI, Fallon J, Freeman PR. Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections. Microorganisms. 2023;11(9):2301. doi:10.3390/microorganisms11092301

BibTeX
@article{Horowitz2023,
  author = {Horowitz, Richard I and Fallon, John and Freeman, Phyllis R},
  title = {Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections},
  journal = {Microorganisms},
  year = {2023},
  volume = {11},
  number = {9},
  pages = {2301},
  doi = {10.3390/microorganisms11092301}
}
Kostenlos starten →